bioRxivBiophysicsPreprint
Liver Viscosity Decreases Before the Onset of Fibrosis in Metabolic Dysfunction-Associated 1 Steatohepatitis (MASH)
Yasmine SafraouiD, Kristin Susan SpirgathiD, Biru HuangiD, Christian BayerliD, Karolina KrehliD, Anja Andrea KühliD, Tom MeyeriD, Mehrgan ShahryariiD, Pedro Augusto Dantas de MoraesiD, Jakob Ernst Luis JordaniD, Noah JaitneriD, Dominik GeiseliD, Jörg SchnorriD, Nicola StolzenburgiD, Michael MüllederiD, Kathrin Textoris‐TaubeiD, Iwona WallachiD, Nikolaus BerndtiD, Heiko TzschätzschiD, Rebecca G. WellsiD, Jürgen BrauniD, Patrick AsbachiD, Ingolf SackiD, Jing GuoiD
Abstract
Background and AimMetabolic dysfunction-associated steatohepatitis (MASH) is an increasingly prevalent condition worldwide, associated with biomechanical liver changes and detectable by magnetic resonance elastography (MRE). This study explored the pathophysiological features and their biomechanical manifestations at different stages of MASH in a mouse dietary model. MethodsUsing MRE on a clinical 3 Tesla MRI scanner, we measured liver stiffness, viscosity, fat fraction and water diffusion in 45 male mice. These values were correlated with histopathology and proteomics analyses to further characterize the liver microstructural and metabolic changes during MASH progression. ResultsWe found in a high-fat, low amino-acid model that early MASH was marked by fat accumulation and increasing inflammatory activity, while later stages showed a reduction in fat despite persistent inflammation. These changes in microstructure were associated with biomechanical adaptations, including a progressive decrease in hepatic viscosity and the water diffusion. Notably, viscosity was inversely correlated with lobular inflammation, cell adhesion, antioxidant activity, and metabolic adaptations such as enhanced ketone body synthesis. These findings, which precede the onset of fibrosis and tissue stiffening, show that tissue viscosity is highly sensitive to early microstructural and metabolic alterations in MASH. ConclusionSteatosis and inflammation significantly alter liver biophysical properties, particularly viscosity, in a mouse dietary model of MASH, even in the absence of fibrosis. These findings suggest that viscosity is a potential early and clinically translatable biomarker for the development and progression of MASH.
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Local fat content determines global and local stiffness in livers with simple steatosis
D. Li, P. A. Janmey, R. G. Wells·bioRxiv·Jul 14, 2022
- Metabolomic, Lipidomic, and Enterohormone Changes in the Progression from MASLD to MASH
Jaclyn A. Rivas, Alexandria C. Murphy, … Eliseo F. Castillo·MetabolismPeer-reviewed·May 20, 2026
- Intrahepatic crystals from elevated dietary cholesterol are sufficient to stiffen the liver
David Li, Abigail E. Loneker, … Rebecca G. Wells·Proceedings of the National Academy of SciencesPeer-reviewed·Jan 7, 2026
- Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitis
Ikki Sakuma, Rafael Calais Gaspar, … Gerald I. Shulman·Proceedings of the National Academy of SciencesPeer-reviewed·May 1, 2025
- Global molecular landscape of early MASLD progression in obesity
Qing Zhao, William De Nardo, … Philipp Kaldis·eLifePeer-reviewed·Mar 23, 2026
- Recapitulation of clinical and molecular hallmarks of lipid-induced hepatic insulin resistance in a zonated, vascularized human liver acinus microphysiological system during metabolic dysfunction-associated steatotic liver disease (MASLD) progression
Julio Aleman, Lawrence A. Vernetti, … Mark T. Miedel·BMC BiotechnologyPeer-reviewed·Apr 30, 2026